| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biorestorative Therapies, Inc. (BRTX) has 2 insiders with recent SEC Form 4 filings, including 13 buys and 1 sell. BRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 187.5K | $34.9K | - | |
| VP | 171.4K | $31.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2022 | Broadrick Dale60 | 10% Owner | Buy | 9,213 | $4.46 | $41,122.23 | +3.4% | -29.1% | +19.3% | |
| May 27, 2022 | Broadrick Dale60 | - | Buy | 10,957 | $3.61 | $39,592.02 | +4.3% | -11.5% | +43.4% | |
| May 26, 2022 | Broadrick Dale60 | - | Sell | 2,000 | $3.44 | $6,875.60 | -0.8% | -4.9% | +62.7% | |
| May 26, 2022 | Broadrick Dale60 | - | Buy | 4,950 | $3.51 | $17,364.11 | +1.9% | -4.9% | +62.7% | |
| May 26, 2022 | Alstodt Lance55 | President, CEO, Cob | Buy | 2,700 | $3.52 | $9,494.01 | +1.5% | -4.9% | +62.7% | |
| May 2, 2022 | Alstodt Lance55 | President, CEO, Cob | Buy | 400 | $3.95 | $1,578.80 | +0.1% | -22.9% | +4.3% | |
| Apr 8, 2022 | Kristal Robert Eugene | Chief Financial Officer | Buy | 7,600 | $5.71 | $43,396.00 | New | -39.3% | -36.8% | |
| Apr 6, 2022 | Broadrick Dale60 | - | Buy | 2,500 | $5.66 | $14,150.00 | +1.0% | -39.0% | -36.7% | |
| Apr 5, 2022 | Broadrick Dale60 | - | Buy | 46,000 | $5.71 | $262,640.00 | +10.8% | -40.6% | -38.5% | |
| Mar 31, 2022 | Broadrick Dale60 | 10% Owner | Buy | 15,700 | $4.85 | $76,088.00 | +1.7% | -34.2% | -35.0% |